Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950144-07-006409
Filing Date
2007-07-06
Accepted
2007-07-06 17:14:56
Documents
6

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS INC. g06286a2sv1za.htm S-1/A 2011922
2 EX-23.1 CONSENT OF KPMG LLC g06286a2exv23w1.htm EX-23.1 2803
3 EX-23.3 CONSENT OF MORGAN JOSEPH & CO. INC. g06286a2exv23w3.htm EX-23.3 1647
4 GRAPHIC g06286a2g0628602.gif GRAPHIC 3642
5 GRAPHIC g06286a2g0628603.gif GRAPHIC 4723
6 GRAPHIC g06286a2g0628610.gif GRAPHIC 337
  Complete submission text file 0000950144-07-006409.txt   2030025
Mailing Address
Business Address 209 TENTH AVENUE SOUTH SUITE 332 NASHVILLE, TN 37203
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 07968014
SIC: 2834 Pharmaceutical Preparations